Conserved Neisserial antigens

Details for Australian Patent Application No. 2008249139 (hide)

Owner Novartis Vaccines and Diagnostics S.r.l.

Inventors Rappuoli, Rino

Agent FB Rice

Pub. Number AU-B-2008249139

Parent 2007203665

Filing date 21 November 2008

Wipo publication date 11 December 2008

Acceptance publication date 19 April 2012

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

4 December 2008 Complete Application Filed

11 December 2008 Application Open to Public Inspection

  Published as AU-B-2008249139

19 April 2012 Application Accepted

  Published as AU-B-2008249139

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008249140-Deployment device interface for biopsy device

2008249138-Super hydro power station